Document Detail

Second-generation drug-eluting coronary stents.
MedLine Citation:
PMID:  20445185     Owner:  NLM     Status:  MEDLINE    
Richard A Lange; L David Hillis
Related Documents :
18713645 - Thrombus causes fluctuations in arterial drug delivery from intravascular stents.
15665795 - Drug-eluting stents: clinical perspectives on drug and design differences.
19956555 - Luminal flow amplifies stent-based drug deposition in arterial bifurcations.
21091895 - Controversy of proton pump inhibitor and clopidogrel interaction: a review.
24902935 - The use of estimated glomerular filtration rate for dose adjustment of medications in t...
9833965 - Round window administration of gentamicin: a new method for the study of ototoxicity of...
Publication Detail:
Type:  Comment; Editorial    
Journal Detail:
Title:  The New England journal of medicine     Volume:  362     ISSN:  1533-4406     ISO Abbreviation:  N. Engl. J. Med.     Publication Date:  2010 May 
Date Detail:
Created Date:  2010-05-06     Completed Date:  2010-05-13     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0255562     Medline TA:  N Engl J Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1728-30     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Angioplasty, Transluminal, Percutaneous Coronary
Coronary Artery Disease / therapy*
Cost-Benefit Analysis
Diabetes Complications / therapy
Drug-Eluting Stents*
Paclitaxel / administration & dosage*
Prosthesis Design
Sirolimus / administration & dosage,  analogs & derivatives*
Treatment Outcome
Reg. No./Substance:
159351-69-6/everolimus; 33069-62-4/Paclitaxel; 53123-88-9/Sirolimus
Comment On:
N Engl J Med. 2010 May 6;362(18):1663-74   [PMID:  20445180 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Effect of bar-code technology on the safety of medication administration.
Next Document:  Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2.